3/18
03:40 am
plse
Truffle Capital Unveils the First Edition of the Truffle MedTech 10 [Yahoo! Finance]
Low
Report
Truffle Capital Unveils the First Edition of the Truffle MedTech 10 [Yahoo! Finance]
3/17
07:36 am
plse
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data [Yahoo! Finance]
Medium
Report
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data [Yahoo! Finance]
3/17
07:00 am
plse
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
Low
Report
Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
3/16
12:29 pm
plse
Is Pulse Biosciences' (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? [Yahoo! Finance]
Low
Report
Is Pulse Biosciences' (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? [Yahoo! Finance]
3/16
11:54 am
plse
A Look At Pulse Biosciences (PLSE) Valuation As Thyroid Cancer Feasibility Study Begins [Yahoo! Finance]
Low
Report
A Look At Pulse Biosciences (PLSE) Valuation As Thyroid Cancer Feasibility Study Begins [Yahoo! Finance]
3/12
07:23 am
plse
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology [Yahoo! Finance]
Medium
Report
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology [Yahoo! Finance]
3/12
07:00 am
plse
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
Medium
Report
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
3/9
07:03 am
plse
Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation [Yahoo! Finance]
Low
Report
Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation [Yahoo! Finance]
3/9
07:00 am
plse
Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
Low
Report
Pulse Biosciences Announces Clinical Data From nPulse™ Vybrance™ System First-In-Human Clinical Durability Study of Benign Thyroid Nodule Ablation
3/5
07:00 am
plse
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
Medium
Report
Pulse Biosciences to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
3/4
07:16 am
plse
Pulse Biosciences' nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting [Yahoo! Finance]
Low
Report
Pulse Biosciences' nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting [Yahoo! Finance]
3/4
07:00 am
plse
Pulse Biosciences’ nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting
Low
Report
Pulse Biosciences’ nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting
3/1
03:31 am
plse
Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And Cash Flow Forecasts? [Yahoo! Finance]
Low
Report
Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And Cash Flow Forecasts? [Yahoo! Finance]
2/20
04:05 pm
plse
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/20
10:02 am
plse
Pulse Biosciences (NASDAQ:PLSE) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Medium
Report
Pulse Biosciences (NASDAQ:PLSE) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
2/20
08:42 am
plse
Pulse Biosciences, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
High
Report
Pulse Biosciences, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/20
07:18 am
plse
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference [Yahoo! Finance]
High
Report
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference [Yahoo! Finance]
2/20
07:00 am
plse
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
High
Report
Pulse Biosciences to Present at the 46th Annual TD Cowen Healthcare Conference
2/20
03:01 am
plse
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Pulse Biosciences, Inc. (PLSE) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/20
03:01 am
plse
Pulse Biosciences targets CE Mark submission in 2026 as nPulse platform advances clinical milestones [Seeking Alpha]
High
Report
Pulse Biosciences targets CE Mark submission in 2026 as nPulse platform advances clinical milestones [Seeking Alpha]
2/20
12:16 am
plse
Pulse Biosciences Inc (PLSE) Q4 2025 Earnings Call Highlights: Innovations and Challenges in Focus [Yahoo! Finance]
High
Report
Pulse Biosciences Inc (PLSE) Q4 2025 Earnings Call Highlights: Innovations and Challenges in Focus [Yahoo! Finance]
2/19
10:35 pm
plse
Pulse Biosciences Q4 Earnings Call Highlights [Yahoo! Finance]
High
Report
Pulse Biosciences Q4 Earnings Call Highlights [Yahoo! Finance]
2/19
07:05 pm
plse
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates [Yahoo! Finance]
High
Report
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates [Yahoo! Finance]
2/19
05:02 pm
plse
Pulse Biosciences GAAP EPS of -$0.26 beats by $0.05, revenue of $0.26M beats by $0.01M [Seeking Alpha]
High
Report
Pulse Biosciences GAAP EPS of -$0.26 beats by $0.05, revenue of $0.26M beats by $0.01M [Seeking Alpha]
2/19
04:05 pm
plse
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results
High
Report
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2025 Financial Results